Lack of correlation between fatty acid oxidation disorders and haemolysis, elevated liver enzymes, low platelets (HELLP) syndrome?

Acta Paediatrica, International Journal of Paediatrics

Volumn 94, Issue 1, 2005, Pages 48-52

  Holub, M ^a   Bodamer, O A ^b   Item, C ^b   Muhl A ^b   Pollak, A ^a   Stockler Ipsiroglu S ^a,b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

Fatty acid oxidation defects; Long chain 3 hydroxyacyl CoA dehydrogenase deficiency; Mutation analysis; Pregnancy complications; Tandem mass spectrometry

Indexed keywords

ACYLCARNITINE; FATTY ACID; LIVER ENZYME;

ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CONTROLLED STUDY; ENZYME DEFICIENCY; FATTY ACID OXIDATION; FATTY ACID OXIDATION DISORDER; FEMALE; GENE MUTATION; HELLP SYNDROME; HUMAN; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; NEWBORN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THROMBOCYTE;

3-HYDROXYACYL COA DEHYDROGENASES; ADULT; CARNITINE; CASE-CONTROL STUDIES; DNA MUTATIONAL ANALYSIS; FEMALE; HELLP SYNDROME; HUMANS; INFANT, NEWBORN; MALE; METABOLISM, INBORN ERRORS; PREGNANCY; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 12344290740     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1080/08035250410022486     Document Type: Article

References (31)

1. Roe CR, Ding J. Mitochondrial fatty acid oxidation disorders. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited disease. 8th ed. New York: McGraw Hill; 2001:2291-337.
2. Wanders RJ, Ijlst L, van Gennip H, Jakobs C, de Jager JP, Dorland L, et al. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Identification of a new inborn error of mitochondrial fatty acid β-oxidation. J Inherit Metab Dis 1990;13:311-4.
3. Tyni T, Pihko H. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Acta Paediatr 1999;88:237-45.
4. den Boer ME, Wanders RJ, Morris AA, Ijlst L, Heymans HS, Wijburg FA. Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency: Clinical presentation and follow up in 50 patients. Pediatrics 2002;109:99-104.
5. Rakeheja D, Bennett MJ, Rogers BB. Long-chain L-3-hydroxyacyl-Coenzyme A dehydrogenase deficiency: A molecular and biochemical review. Lab Invest 2002;82:815-24.
6. Tyni T, Kivela T, Lappi M, Summanen P, Nikoskelainen E, Phiko H. Ophthalmologic findings in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency caused by the G1528C mutation: a new type of hereditary metabolic chorioretinopathy. Ophthalmology 1998;105:810-24.
7. Pollitt RJ, Losty H, Westwood A. 3-Hydroxydicarboxylic aciduria: A distinctive type of intermittent dicarboxylic aciduria of possible diagnostic significance. J Inherit Metab Dis 1987;10 Suppl 2:266-72.
8. Millington DS, Terada N, Chace DH, Chen YT, Ding JH, Kodo N, et al. The role of tandem mass spectromety in the diagnosis of fatty acid oxidation disorders. Proc Clin Biol Res 1992;375:330-54.
9. Zytkovicz TH, Fitzgerald EF, Marsden D, Larson CA, Shih VE, Johnson DM, et al. Tandem mass spectrometric analysis for amino, organic, and fatty acid disorders in newborn dried blood spots: a two year summary from the New England Newborn Screening Program. Clin Chem 2001;47:1945-55.
10. Ijlist L, Ruiter JP, Hoovers JM, Jakobs ME, Wanders RJ. Common missense mutation G1528C in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. J Clin Invest 1996;98:1028-33.
11. Gillingham M, Van Calcar S, Ney D, Wolff J, Harding C. Dietary management of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (LCHADD). A case report and survey. J Inherit Metab Dis 1999;22:123-31.
12. Strauss AW, Bennet MJ, Rinaldo P, Sims HF, O'Brien LK, Zhao J, et al. Inherited long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency and fetal-maternal interactions cause maternal liver disease and other pregnancy complications. Semin Perinatol 1999;23:100-12.
13. Ibdah JA, Bennet MJ, Rinaldo P, Zhao Y, Gibson B, Sims HF, et al. A fetal fatty acid oxidation disorder as a cause of liver disease in pregnant women. N Engl J Med 1999;340:1723-31.
14. Sims HF, Brackett JC, Powell CK, Treem WR, Hale DE, Bennet MJ, et al. The molecular basis of pediatric long chain-3-hydroxyacyl-CoA dehydrogenase deficiency associated with maternal acute fatty liver of pregnancy. Proc Natl Acad Sci USA 1995;92:841-5.
15. Treem WR, Shoup ME, Hale DE, Bennet MJ, Rinaldo P, Millington DS, et al. Acute fatty liver of pregnancy, hemolysis, elevated liver enzymes, and low platelets syndrome, and long chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Am J Gastroenterol 1996;91:2293-300.
16. Isaacs JD, Sims HF, Powell CK, Powell CK, Bennet MJ, Hale DE, et al. Maternal acute fatty liver of pregnancy associated with fetal trifunctional protein deficiency: Molecular characterisation of a novel maternal mutant allele. Pediatr Res 1996;40:393-8.
17. Tyni T, Ekholm E, Phiko H. Pregnancy complications are frequent in long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency. Am J Obstet Gynecol 1998;178:603-8.
18. Matern D, Hart P, Murtha AP, Vockley J, Gregersen N, Millington DS, et al. Acute fatty liver of pregnancy associated with short-chain acyl-coenzyme A dehydrogenase deficiency. J Pediatr 2001;138:585-8.
19. Innes AM, Seargeant LE, Balachandra K, Roe CR, Wanders RJ, Ruiter JP, et al. Hepatic carnitine palmitoyltransferase I deficiency presenting as maternal illness in pregnancy. Pediatr Res 2000;47:43-5.
20. Egerman RS, Sibai BM. HELLP Syndrome. Clin Obstet Gynecol 1999;42:381-9.
21. Bodamer OA, Möslinger D, Mühl A, Stöckler-Ipsiroglu S. Neonatal screening in Austria: Current situation, new developments, and future perspectives. Pädiat Prax 2002;61:539-49.
22. Walsh P, Metzger DA, Higuchi R. Chelex-100 as a medium for simple extraction of DNA for PCR-based typing from forensic material. Biotechniques 1991;10:506-13.
23. Item C, Hagerty BP, Mühl A, Greber-Platzer S, Stöckler- Ipsiroglu S, Strobl W. Mutations in the galactose-1-p-uridyltransferase gene in infants with a positive galactosemia newborn screening test. Pediatr Res 2002;51:511-6.
24. den Boer ME, Ijlst L, Wijburg F, Oostheim W, van Werkhoven MA, van Rampus MG, Heymans HS, et al. Heterozygosity for the common LCHAD mutation (1528G > C) is not a major cause of HELLP-syndrome and the prevalence of the mutation in the Dutch population is low. Pediatr Res 2000;48:151-4.
25. Raval DS, Co S, Reid MA, Pildes R. Maternal and neonatal outcome of pregnancies complicated with maternal HELLP syndrome. J Perinatol 1997;17:266-9.
26. Holzgreve W, Li J, Steinborn A, Külz T, John C, Hodel M, et al. Elevation in erythroblast count in maternal blood before the onset of preeclampsia. Am J Obst Gynec 2001;184:165-8.
27. Barton JR, Riely CA, Adamec TA, Shanklin DR, Khoury AD, Sibai BM. Hepatic histopathologic condition does not correlate with laboratory abnormalities in HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count). Am J Obstet Gynecol 1992;167:1538-42.
28. Yang Z, Yamada J, Zhao Y, Strauss AW, Ibdah JA. Prospective screening for pediatric mitochondrial trifunctional protein defects in pregnancies complicated by liver disease. JAMA 2002;288:2163-6.
29. Rinaldo P, Studinski AL, Matern D. Prenatal diagnosis of disorders of fatty acid transport and mitochondrial oxidation. Prenat Diagn 2001;21:52-4.
30. Shortland GJ, Walter JH, Stroud C, Fleming PJ, Speidl BD, Marlow N. Randomised controlled trial of L-carnitine as a nutritional supplement in preterm infants. Arch Dis Child Fetal Neonatal Ed 1998;78:F185-8.
31. Maitra A, Domaiti-Saad R, Yost N, Cunningham G, Rogers BB, Bennet MJ. Absence of the G1528C (E474Q) mutation in the α-subunit of the mitochondrial trifunctional protein in women with acute fatty liver of pregnancy. Pediatr Res 2002;51:658-61.